We are live on
!
Find out more
HI
Human Investing Portfolio holdings
AUM
$771M
1-Year Est. Return
18.84%
This Fund
S&P 500
This Quarter
Est. Return
+6.21%
1 Year Est. Return
+18.84%
3 Year Est. Return
+51.96%
5 Year Est. Return
+53.41%
10 Year Est. Return
–
AUM
$419M
AUM Growth
-$4.7M
(-1.1%)
Cap. Flow
-$26.7M
Cap. Flow
% of AUM
-6.36%
Top 10 Holdings %
Top 10 Hldgs %
67.19%
Holding
115
New
2
Increased
33
Reduced
33
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.16M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.87M |
| 3 |
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
|
+$1.29M |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.09M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.85M |
| 2 |
Home Depot
HD
|
+$2.6M |
| 3 |
Microsoft
MSFT
|
+$2.24M |
| 4 |
Amgen
AMGN
|
+$1.78M |
| 5 |
Accenture
ACN
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.12% |
| 2 | Healthcare | 3.8% |
| 3 | Consumer Staples | 1.9% |
| 4 | Consumer Discretionary | 1.67% |
| 5 | Financials | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Employers Holdings
EIG
$908M
| $1.24M | 0.3% |
29,937
-221
| -0.7% | -$8.88K |
|
52
Gilead Sciences
GILD
$162B
| $1.21M | 0.29% |
16,595
-265
| -2% | -$18.3K |
|
53
Colgate-Palmolive
CL
$73.1B
| $1.19M | 0.28% |
13,889
-30
| -0.2% | -$2.34K |
|
54
Bristol-Myers Squibb
BMY
$133B
| $1.11M | 0.27% |
17,821
+97
| +0.5% | +$5.69K |
|
55
Amdocs
DOX
$5.92B
| $1.09M | 0.26% |
14,558
-118
| -0.8% | -$8.86K |
|
56
LyondellBasell Industries
LYB
$20B
| $1.07M | 0.26% |
11,593
-159
| -1% | -$14.8K |
|
57
Emerson Electric
EMR
$83.9B
| $1.04M | 0.25% |
11,139
-230
| -2% | -$21.7K |
|
58
NetApp
NTAP
$35B
| $1.03M | 0.25% |
11,187
+443
| +4% | +$39.9K |
|
59
Virtu Financial
VIRT
$5.11B
| $1.02M | 0.24% |
35,374
+380
| +1% | +$10.4K |
|
60
General Mills
GIS
$19.1B
| $1.01M | 0.24% |
14,935
-287
| -2% | -$18.2K |
|
61
GSK
GSK
$104B
| $1M | 0.24% |
18,240
-158
| -0.9% | -$8.22K |
|
62
Unilever
UL
$137B
| $958K | 0.23% |
15,833
-59
| -0.4% | -$3.5K |
|
|
CTRA
63
DELISTED
Coterra Energy
CTRA
| $927K | 0.22% |
+48,783
| New | +$1.02M |
|
64
Hormel Foods
HRL
$13.8B
| $868K | 0.21% |
17,778
-262
| -1% | -$11.5K |
|
|
K
65
DELISTED
Kellanova
K
| $845K | 0.2% |
13,962
-921
| -6% | -$54.4K |
|
66
ONE Gas
OGS
$4.87B
| $805K | 0.19% |
10,376
-2,813
| -21% | -$196K |
|
67
Schwab International Equity ETF
SCHF
$66.6B
| $669K | 0.16% |
34,410
+324
| +1% | +$6.36K |
|
68
AT&T
T
$159B
| $563K | 0.13% |
30,297
-11,953
| -28% | -$223K |
|
69
iShares Silver Trust
SLV
$28B
| $218K | 0.05% |
10,114
| – | – |
|
70
Abbott
ABT
$183B
| – | – |
-8,677
| Closed | -$1.02M |
|
|
71
Accenture
ACN
$102B
| – | – |
-4,175
| Closed | -$1.34M |
|
72
iShares Core US Aggregate Bond ETF
AGG
$137B
| – | – |
-3,212
| Closed | -$369K |
|
73
Allstate
ALL
$68B
| – | – |
-8,911
| Closed | -$1.13M |
|
|
74
Amgen
AMGN
$208B
| – | – |
-8,366
| Closed | -$1.78M |
|
75
Amazon
AMZN
$2.92T
| – | – |
-2,800
| Closed | -$459K |
|
Similar funds
WI
CCA
PGA
SC
PA
BPIM
TCM
PC
Human Investing's Q4 2021 Portfolio in Review
As of Q4 2021, Human Investing held 115 positions worth $419M, down 1.1% from $424M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Human Investing withdrew a net $26.7M in Q4 2021, closing 46 positions and reducing 33 holdings. Its most notable exit was Broadcom, an estimated $2.85M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 6.9% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Human Investing opened a new position in State Street SPDR S&P 400 Mid Cap Value ETF worth $1.31M.
- Human Investing's largest Q4 2021 buy was State Street SPDR S&P 400 Mid Cap Value ETF: 18,486 shares worth $1.31M.
- Human Investing added most to Vanguard S&P 500 ETF in Q4 2021, an estimated $4.16M increase.
- Human Investing's biggest Q4 2021 reduction was Novo Nordisk, cutting an estimated $632K.
- Human Investing fully exited Broadcom in Q4 2021, selling an estimated $2.85M.
- Human Investing's ten largest holdings make up 67% of its $419M portfolio in Q4 2021.
- Human Investing opened 2 new positions and closed 46 in Q4 2021.
- Human Investing's portfolio value fell 1.1% quarter-over-quarter to $419M.
Based on Human Investing's 13F filing for Q4 2021, filed 10 Feb 2022.